NUVL
NuvalentCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
Composite grade C from latest DB weights. Momentum 55.6 / Value 41.1
Posture
Mixed
Lead driver
Momentum
What changed
2 setup hits (3d) with net bearish as of 2026-06-02.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
56
Value
41
Sentiment
N/A
Setup hits (3d)
2 · Net Bearish
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Bearish
Target $143.53
Why
Momentum56 · Δ7d +9.9
Value41 · Δ7d +0.1
SentimentN/A · Δ7d -
So what
Balanced signals (Net Bearish). Wait for confirmation before sizing up.
Lead driver: Momentum · See technicals
Momentum
56
52% active weight
Current posture
7d trendSoftening
Δ7d
+9.9
Δ21d
+6.4
Value
41
48% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.2
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade C. Momentum 55.6 / Value 41.1
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$7.35B
Beta
1.32
Shares Out
77.22M
P/E (TTM) · Derived
-16.3
P/S (TTM)
-
P/FCF (TTM) · Derived
-25.85
Rev YoY
-
EPS YoY
-32.2%
Gross Margin
-
Op Margin
-
Net Debt
-$1.12B
Current Ratio
10.73
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology